Afanasieva, O.; Ezhov, M.V.; Klesareva, E.; Razova, O.; Chubykina, U.; Egiazaryan, M.; Sherstyuk, E.; Afanasieva, M.; Utkina, E.; Pokrovsky, S.
Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level. J. Cardiovasc. Dev. Dis. 2020, 7, 45.
https://doi.org/10.3390/jcdd7040045
AMA Style
Afanasieva O, Ezhov MV, Klesareva E, Razova O, Chubykina U, Egiazaryan M, Sherstyuk E, Afanasieva M, Utkina E, Pokrovsky S.
Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level. Journal of Cardiovascular Development and Disease. 2020; 7(4):45.
https://doi.org/10.3390/jcdd7040045
Chicago/Turabian Style
Afanasieva, Olga, Marat V. Ezhov, Elena Klesareva, Oksana Razova, Uliana Chubykina, Mane Egiazaryan, Ekaterina Sherstyuk, Marina Afanasieva, Elena Utkina, and Sergei Pokrovsky.
2020. "Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level" Journal of Cardiovascular Development and Disease 7, no. 4: 45.
https://doi.org/10.3390/jcdd7040045
APA Style
Afanasieva, O., Ezhov, M. V., Klesareva, E., Razova, O., Chubykina, U., Egiazaryan, M., Sherstyuk, E., Afanasieva, M., Utkina, E., & Pokrovsky, S.
(2020). Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level. Journal of Cardiovascular Development and Disease, 7(4), 45.
https://doi.org/10.3390/jcdd7040045